Literature DB >> 30593893

Neurological diseases at the blood-brain barrier: Stemming new scientific paradigms using patient-derived induced pluripotent cells.

Shyanne Page1, Ronak Patel1, Snehal Raut1, Abraham Al-Ahmad2.   

Abstract

The blood-brain barrier (BBB) is a component of the neurovascular unit formed by specialized brain microvascular endothelial cells (BMECs) surrounded by a specific basement membrane interacting with astrocytes, neurons, and pericytes. The BBB plays an essential function in the maintenance of brain homeostasis, by providing a physical and chemical barrier against pathogens and xenobiotics. Although the disruption of the BBB occurs with several neurological disorders, the scarcity of patient material source and lack of reliability of current in vitro models hindered our ability to model the BBB during such neurological conditions. The development of novel in vitro models based on patient-derived stem cells opened new venues in modeling the human BBB in vitro, by being more accurate than existing in vitro models, but also bringing such models closer to the in vivo setting. In addition, patient-derived models of the BBB opens the avenue to address the contribution of genetic factors commonly associated with certain neurological diseases on the BBB pathophysiology. This review provides a comprehensive understanding of the BBB, the current development of stem cell-based models in the field, the current challenges and limitations of such models.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood-brain barrier; Diseases modeling; Endothelial cells; Induced pluripotent stem cells; Neurological diseases; Stem cells

Year:  2018        PMID: 30593893     DOI: 10.1016/j.bbadis.2018.12.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  5 in total

1.  In Vitro Models of the Blood-Brain Barrier.

Authors:  Snehal Raut; Aditya Bhalerao; Behnam Noorani; Luca Cucullo
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Evolution of adrenoleukodystrophy model systems.

Authors:  Roberto Montoro; Vivi M Heine; Stephan Kemp; Marc Engelen
Journal:  J Inherit Metab Dis       Date:  2021-01-07       Impact factor: 4.982

Review 3.  In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.

Authors:  Sounak Bagchi; Tanya Chhibber; Behnaz Lahooti; Angela Verma; Vivek Borse; Rahul Dev Jayant
Journal:  Drug Des Devel Ther       Date:  2019-10-18       Impact factor: 4.162

4.  Healthy Serum-Derived Exosomes Improve Neurological Outcomes and Protect Blood-Brain Barrier by Inhibiting Endothelial Cell Apoptosis and Reversing Autophagy-Mediated Tight Junction Protein Reduction in Rat Stroke Model.

Authors:  Lin-Yan Huang; Jin-Xiu Song; Heng Cai; Pei-Pei Wang; Qi-Long Yin; Yi-De Zhang; Jie Chen; Ming Li; Jia-Jia Song; Yan-Ling Wang; Lan Luo; Wan Wang; Su-Hua Qi
Journal:  Front Cell Neurosci       Date:  2022-03-03       Impact factor: 5.505

5.  Brain Delivery of a Potent Opioid Receptor Agonist, Biphalin during Ischemic Stroke: Role of Organic Anion Transporting Polypeptide (OATP).

Authors:  Thamer H Albekairi; Bhuvaneshwar Vaidya; Ronak Patel; Saeideh Nozohouri; Heidi Villalba; Yong Zhang; Yeon Sun Lee; Abraham Al-Ahmad; Thomas J Abbruscato
Journal:  Pharmaceutics       Date:  2019-09-10       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.